Immunomodulation for the Treatment of Chronic Chagas Disease Cardiomyopathy: A New Approach to an Old Enemy
Chagas disease is a parasitic infection caused by the intracellular protozoan Trypanosoma cruzi. Chronic Chagas cardiomyopathy (CCC) is the most severe manifestation of the disease, developed by approximately 20-40% of patients and characterized by occurrence of arrhythmias, heart failure and death....
Guardado en:
Autores principales: | Emanuelle de Souza Santos, Dahara Keyse Carvalho Silva, Bruna Padilha Zurita Claro dos Reis, Breno Cardim Barreto, Carine Machado Azevedo Cardoso, Ricardo Ribeiro dos Santos, Cássio Santana Meira, Milena Botelho Pereira Soares |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f72f181d972a4d3c8667e4a95c95e2da |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
EFFICACY AND SAFETY OF IMMUNOMODULATORS APPLICATION IN PREVENTION OF COMPLICATIONS IN PATIENTS WITH PERTUSSIS
por: L. M. Panasenko, et al.
Publicado: (2012) -
IMMUNOMODULATORS IN OPPORTUNISTIC INFECTIONS TREATMENT
por: A. P. Toptygina, et al.
Publicado: (2014) -
IMMUNOMODULATING PROPERTIES OF THE PLANT GLUCANS AT EXPERIMENTAL IMMUNODEPRESSION
por: V. B. Khobrakova, et al.
Publicado: (2012) -
COMPARATIVE STUDIES OF IMMUNOMODULATING PROPERTIES OF C HITOSAN AND ITS DERIVATIVES
por: L. A. Ivanushko, et al.
Publicado: (2014) -
Therapeutic effects of sphingosine kinase inhibitor N,N-dimethylsphingosine (DMS) in experimental chronic Chagas disease cardiomyopathy
por: Juliana Fraga Vasconcelos, et al.
Publicado: (2017)